Cannabis Does Not Impact Nonmedical Opioid Use in Opioid Use Disorder

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 16, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 16, 2024 -- For patients receiving pharmacotherapies for opioid use disorder (OUD), cannabis use is not associated with nonmedical opioid use, according to a systematic review and meta-analysis published online Jan. 16 in the American Journal of Drug and Alcohol Abuse.

Gabriel P.A. Costa, from the University of Ribeirão Preto in Brazil, and colleagues examined the impact of cannabis use on the risk for nonmedical opioid use among individuals receiving pharmacotherapies for OUD. Ten studies, with 8,367 participants and an average follow-up time of 9.7 months, were included in the final meta-analysis.

The pharmacotherapies involved were methadone, buprenorphine, and naltrexone (76.3, 21.3, and 2.4 percent, respectively). The researchers found that based on pooled odds ratios, cannabis use did not significantly influence nonmedical opioid use (odds ratio, 1.00; 95 percent confidence interval, 0.97 to 1.04; P = 0.98). Evidence of moderate heterogeneity and publication bias was observed.

"These findings neither confirm concerns about cannabis increasing nonmedical opioid use in individuals being treated for opioid use disorder, nor do they endorse its efficacy in reducing nonmedical opioid use," Costa said in a statement.

One author disclosed ties to Jazz Pharmaceuticals and Boehringer Ingelheim.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-17 04:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords